On January xxx, The BioCentury Show will feature an in-depth conversation with Scott Gottlieb about pandemic preparedness, regulatory innovation and FDA’s future. As FDA commissioner, Gottlieb brought new ideas and energy to the agency, earning praise from across the political spectrum and from patient advocates, medical product developers and public health experts. After leaving FDA, he was among the first to call for a strong response to COVID-19 and has been one of the most trusted voices in public debates over pandemic policy. Gottlieb serves on the boards of Pfizer, Illumina and other companies and is a venture capital partner.

On January xxx, The BioCentury Show will feature an in-depth conversation with Scott Gottlieb about pandemic preparedness, regulatory innovation and FDA’s future. As FDA commissioner, Gottlieb brought new ideas and energy to the agency, earning praise from across the political spectrum and from patient advocates, medical product developers and public health experts. After leaving FDA, he was among the first to call for a strong response to COVID-19 and has been one of the most trusted voices in public debates over pandemic policy. Gottlieb serves on the boards of Pfizer, Illumina and other companies and is a venture capital partner.